Gastric Neuroendocrine Carcinoma in Bearded Dragons: Signs, Diagnosis and Prognosis

By Dr Duncan Houston

A young bearded dragon that stops eating, loses weight or begins regurgitating is more likely to have a husbandry, gastrointestinal, infectious or parasitic problem than cancer.

However, bearded dragons are also predisposed to a rare and highly malignant stomach cancer called gastric neuroendocrine carcinoma. The warning signs are frustratingly vague, and by the time a stomach or liver mass becomes obvious, the cancer may already have spread.

The key is not to panic over every missed meal. It is to recognise when reduced appetite has become persistent, progressive or associated with weight loss, anaemia, gastrointestinal bleeding or severe unexplained hyperglycaemia.

Quick Answer

Gastric neuroendocrine carcinoma is an aggressive cancer arising from neuroendocrine cells within the bearded dragon’s stomach. It commonly causes appetite loss, weight loss, weakness, regurgitation or vomiting-like episodes and may be associated with anaemia, black droppings and severe hyperglycaemia.

Diagnosis usually requires blood testing, ultrasound or CT and microscopic examination of cells or tissue. The prognosis is generally poor because reported tumours have frequently already spread to the liver and other organs by the time they are diagnosed. (PubMed)

Gastric Neuroendocrine Carcinoma at a Glance

Question	Practical answer
What is it?	A malignant tumour arising from hormone-producing neuroendocrine cells in the stomach
Which dragons are most affected?	Published cases have occurred predominantly in young bearded dragons, often around one to three years old
Most common signs	Appetite loss, weight loss, lethargy, weakness, regurgitation or vomiting
Important laboratory clues	Anaemia and severe unexplained hyperglycaemia
Where does it spread?	Most commonly the liver, but also the kidneys, pancreas, intestines, lungs, spleen, heart and reproductive organs
How is it confirmed?	Cytology or biopsy followed by histopathology and, where needed, immunohistochemistry
Is there a standard treatment?	No validated treatment protocol currently exists
Typical prognosis	Poor to grave once metastasis is present

The initial ten-case series found stomach tumours in every dragon and hepatic metastasis in every case. Other organs were also affected in several animals. (Sage Journals)

What Is a Gastric Neuroendocrine Carcinoma?

Neuroendocrine cells are specialised cells that receive nerve-like signals and release hormones or hormone-like substances.

Small populations of these cells normally occur throughout the gastrointestinal tract. Gastric neuroendocrine carcinoma develops when one of these cell populations becomes malignant and begins growing within the stomach wall.

Reported tumours have commonly developed beneath the gastric lining, formed firm pale nodules and projected into the stomach. Some have ulcerated through the mucosa, creating gastrointestinal bleeding and black, digested blood within the stomach or droppings. (Sage Journals)

Why “Carcinoma” Is More Accurate Than “Tumour”

“Neuroendocrine tumour” is a broad term that can include less aggressive and malignant growths.

The bearded dragon disease described in the veterinary literature has behaved as a carcinoma because it:

• Invades surrounding stomach tissue

• Enters veins and lymphatic vessels

• Spreads to distant organs

• Is commonly associated with death or euthanasia

For this particular bearded dragon syndrome, gastric neuroendocrine carcinoma is therefore the more clinically useful term. (Wiley Online Library)

Is It the Same as a Somatostatinoma?

Some gastric neuroendocrine carcinomas in bearded dragons produce somatostatin and can be classified as malignant somatostatinomas.

In the original study, all five tumours that received extended hormone testing expressed somatostatin. Several also expressed other hormones, indicating that the tumours could be multihormonal. Later case reports have also documented somatostatin expression, although the strength and consistency of staining have varied. (Sage Journals)

Somatostatin can suppress:

• Insulin release

• Gastrointestinal movement

• Gastric secretion

• Intestinal absorption

• Other digestive hormones

Researchers have therefore proposed that some affected dragons develop a hormone-related syndrome resembling human somatostatinoma syndrome. Hyperglycaemia, weight loss and anaemia support that possibility, but a complete functional hormone syndrome has not been proved in bearded dragons. (PubMed)

A suspected stomach mass should not automatically be labelled a somatostatinoma without appropriate pathological testing.

Is This Cancer Becoming More Common?

It is being recognised more often, but there is no reliable population study proving that its true incidence is rising.

The initial pathology investigation estimated that gastric neuroendocrine carcinomas represented approximately 1.5% of bearded dragon submissions to one specialist pathology archive. A later retrospective study estimated that they represented approximately 2.8% of diagnosed bearded dragon neoplasms. These percentages came from selected biopsy and necropsy submissions, not from random screening of healthy pet dragons. (Sage Journals)

Bearded dragons also appear over-represented among captive lizards diagnosed with cancer generally. However, that may reflect several interacting factors:

• Their popularity as pets

• Increased longevity

• Improved veterinary imaging and pathology

• Greater owner willingness to investigate illness

• Possible species or genetic susceptibility

• Referral and submission bias

A UK pathology review found that bearded dragons had a higher proportion of neoplasia diagnoses than the overall submitted lizard population, but the researchers could not determine whether that difference arose from genetics, husbandry or other factors. (BVA Journals)

Which Bearded Dragons Are Most at Risk?

Published gastric neuroendocrine carcinoma cases have predominantly involved young dragons.

In the original series, known ages clustered around approximately one to three years. Additional case reports have involved dragons aged two, two and a half and three years. Both males and females have been affected. (Sage Journals)

This is clinically important because cancer is often dismissed in a young reptile.

A dragon does not need to be old before cancer becomes a reasonable differential diagnosis. At the same time, most young dragons with appetite loss do not have gastric neuroendocrine carcinoma.

The combination of signs matters far more than age alone.

How Does This Cancer Behave?

Reported gastric neuroendocrine carcinomas are highly metastatic.

In the original series:

• Every dragon had a primary stomach tumour microscopically.

• Every dragon had liver involvement.

• Several had spread to the kidneys or pancreas.

• Other metastatic sites included the intestines, spleen, lungs, heart, ovary and oviduct.

• Two dragons had no obvious tumour visible during gross examination, despite microscopic disease being present. (Sage Journals)

This last point matters. A tumour may be:

• Small

• Submucosal

• Hidden beneath apparently normal stomach tissue

• Difficult to palpate

• Inconspicuous on basic radiographs

• Overshadowed by secondary liver disease

The absence of an obvious abdominal lump does not rule it out.

What Are the Signs of Gastric Neuroendocrine Carcinoma?

The most consistent warning sign is persistent appetite loss.

Appetite and Weight Changes

Affected dragons may show:

• Reduced appetite

• Complete anorexia

• Progressive weight loss

• Loss of muscle over the limbs, tail base or spine

• Failure to grow or thrive

• Cachexia despite supportive feeding

Eight of ten dragons in the original series had reported anorexia. Other published cases presented after weeks or months of reduced appetite and progressive weight loss. (PubMed)

Gastrointestinal Signs

Possible signs include:

• Regurgitation

• Vomiting-like episodes

• Diarrhoea

• Reduced stool production

• Abdominal discomfort

• A palpable coelomic mass

• Black, tarry droppings

• Fresh gastrointestinal bleeding

A 2.5-year-old dragon with a somatostatin-expressing tumour developed chronic appetite loss, weight loss and depression before suddenly passing black digested blood. The stomach mass was ulcerated and multiple hepatic metastases were already present. (Sage Journals)

General Signs

Owners may notice:

• Lethargy

• Reduced basking

• Weakness

• Less climbing

• Reduced interaction

• Difficulty supporting the body

• Dehydration

• Progressive decline despite treatment

These signs are not specific to cancer. They become more concerning when they persist despite correction of temperature, hydration, diet and other obvious husbandry problems.

Anaemia and Bleeding

Anaemia has been documented in several affected dragons.

Possible mechanisms include:

• Chronic bleeding from an ulcerated stomach mass

• Inflammation

• Advanced systemic disease

• Reduced food intake

• Bone-marrow or metabolic effects

Anaemia becomes more suspicious when it occurs with weight loss, dark droppings, a stomach mass or severe unexplained hyperglycaemia. (PubMed)

Does High Blood Glucose Mean a Bearded Dragon Has This Cancer?

No.

Severe unexplained hyperglycaemia is an important clue, not a diagnosis.

In the original ten-case series, only two dragons had reported severe hyperglycaemia, although blood results were unavailable for many of the others. Later ante-mortem cases had glucose values around 786 mg/dL and severe hyperglycaemia associated with gastric and hepatic masses. (Sage Journals)

The pattern becomes particularly concerning when a young dragon has:

• Persistent anorexia

• Progressive weight loss

• Anaemia

• Regurgitation

• A stomach or liver mass

• Severe persistent hyperglycaemia

Why One High Glucose Result Is Not Enough

Glucose must be interpreted alongside:

• Feeding status

• Sampling and laboratory method

• Previous results

• Fluid therapy

• Medications

• Hydration

• The dragon’s clinical condition

In one controlled study, a dextrose-containing reptile fluid mixture increased mean bearded dragon glucose from approximately 190 mg/dL to more than 400 mg/dL, with the increase persisting for at least 24 hours. That is lower than the most extreme tumour-associated values, but it demonstrates how treatment history can change interpretation. (PubMed)

A single high result does not confirm cancer.

A single normal result does not rule it out either.

Should Healthy Young Bearded Dragons Have Routine Glucose Screening?

There is no validated glucose-based screening programme for gastric neuroendocrine carcinoma.

Glucose may form part of a wellness blood profile, but it has several limitations:

• Not every affected dragon is hyperglycaemic.

• Hyperglycaemia is not specific to this cancer.

• No validated screening threshold exists.

• A normal result cannot rule out a small or non-functional tumour.

• Bloodwork cannot show whether metastasis is present.

Routine examinations and baseline bloodwork may still help identify changes earlier, particularly when previous values are available. However, a glucose value should be interpreted as part of the entire patient rather than advertised as a stand-alone cancer test. (PubMed)

What Else Can Cause These Signs?

Gastric neuroendocrine carcinoma is only one differential for appetite loss, weight loss or regurgitation.

Possible condition	How it can resemble gastric cancer
Gastrointestinal impaction or foreign material	Appetite loss, reduced stool, regurgitation and abdominal enlargement
Parasites or coccidiosis	Weight loss, diarrhoea, poor appetite and reduced condition
Adenoviral disease	Poor growth, appetite loss, weakness and gastrointestinal or neurological signs
Hepatic lipidosis or other liver disease	Anorexia, lethargy, weight loss and abnormal coelomic imaging
Bacterial or fungal disease	Inflammation, appetite loss, weakness and abnormal blood results
Reproductive disease	Appetite loss, abdominal enlargement, weakness and coelomic masses
Gastric ulceration without cancer	Melena, anaemia, pain and reduced appetite
Lymphoma or leukaemia	Weight loss, anorexia, anaemia and multi-organ involvement
Other stomach or intestinal tumours	Similar gastrointestinal and coelomic signs
Pancreatic or hepatobiliary tumours	Appetite loss, abdominal masses, altered blood results and weight loss

A 2022 retrospective investigation identified neuroendocrine carcinoma, lymphoma or other round-cell disease, adenocarcinoma and sarcoma among bearded dragon gastric tumours. Every oesophageal, gastric and intestinal tumour in that selected pathology series was associated with death or euthanasia. (PubMed)

The features that make gastric neuroendocrine carcinoma more suspicious are the combination of young age, progressive gastrointestinal signs, anaemia, severe unexplained hyperglycaemia and gastric or hepatic masses.

How Is Gastric Neuroendocrine Carcinoma Diagnosed?

Diagnosis usually requires several stages.

1. History and Physical Examination

The veterinarian will ask about:

• Current and previous weight

• Appetite trend

• Regurgitation or diarrhoea

• Stool colour

• Last normal bowel movement

• Diet and supplementation

• Basking and cool-zone temperatures

• UVB lighting

• Previous medications and fluids

• Reproductive history

• Previous parasite testing

• Duration and progression of the signs

The examination may identify:

• Muscle loss

• Dehydration

• Pale oral tissues

• Coelomic enlargement

• A palpable mass

• Pain or resistance during coelomic palpation

• Reduced strength

• Other disease unrelated to the stomach

A normal physical examination does not exclude the tumour. One published dragon with chronic appetite loss and weight loss had no palpable or auscultable abnormality before deteriorating. (Sage Journals)

2. Complete Blood Count and Chemistry

Potential findings include:

• Anaemia

• Leukocytosis

• Heterophilia

• Inflammatory changes

• Severe hyperglycaemia

• Protein abnormalities

• Secondary liver or organ changes

In a 2024 cytological case, the affected dragon had severe anaemia, leukocytosis, heterophilia and glucose of 786 mg/dL. These findings supported concern but did not establish the final tumour type by themselves. (Wiley Online Library)

Bloodwork is valuable for assessing:

• Severity

• Hydration

• Anaesthetic risk

• Organ function

• Whether biopsy or surgery is reasonable

• Competing diagnoses

It cannot independently confirm gastric neuroendocrine carcinoma.

3. Radiographs

Whole-body radiographs can identify:

• Coelomic organ displacement

• A large soft-tissue opacity

• Gastrointestinal obstruction

• Mineral foreign material

• Skeletal disease

• Reproductive material

• Some advanced masses

However, small gastric lesions or early liver metastases may be difficult to distinguish.

Radiographs are best treated as an initial screening tool rather than a reliable exclusion test.

4. Ultrasound

Ultrasound may identify:

• Thickening or nodules within the stomach wall

• A discrete gastric mass

• Liver nodules

• Pancreatic or renal involvement

• Abdominal fluid

• Other coelomic abnormalities

In one ante-mortem case, ultrasound and CT identified both gastric and hepatic masses before cytology confirmed a malignant neuroendocrine tumour. (ScienceDirect)

Ultrasound can also guide fine-needle aspiration of accessible liver or abdominal lesions.

5. CT

CT may provide better assessment of:

• Exact tumour location

• Gastric-wall involvement

• Liver metastasis

• Additional organ involvement

• Surgical accessibility

• Small lesions that are difficult to separate on radiographs

CT does not replace tissue diagnosis. It helps determine where the tumour is and whether attempting surgery is realistic.

6. Cytology

Fine-needle aspiration can provide a less invasive ante-mortem diagnosis.

Cytology may be collected from:

• A gastric mass

• A hepatic nodule

• Another suspected metastatic lesion

A 2019 case was diagnosed ante-mortem after ultrasound and CT identified stomach and liver masses and cytology of the hepatic lesion demonstrated a malignant neuroendocrine pattern. A later publication also described the cytological diagnosis of a stomach mass in a three-year-old dragon. (ScienceDirect)

Cytology may establish a strong diagnosis, but some samples are difficult to classify because reptile neuroendocrine tumours do not always show classic or uniform cellular features.

7. Biopsy, Histopathology and Immunohistochemistry

Histopathology examines the architecture of a tissue sample and remains the most definitive method of identifying:

• Tumour origin

• Cellular differentiation

• Invasion

• Vascular or lymphatic spread

• Ulceration

• Metastasis

Immunohistochemistry may assess markers including somatostatin and other neuroendocrine proteins. Marker performance can vary because many antibodies were developed for mammalian tissue rather than reptiles.

A negative result for one marker does not automatically exclude neuroendocrine origin. Diagnosis depends on the combined microscopic appearance, distribution, staining pattern and clinical findings. (Sage Journals)

8. Staging

Once cancer is suspected, the more important question becomes whether it is localised or metastatic.

Staging may include:

• Complete coelomic ultrasound

• CT

• Sampling liver nodules

• Evaluation of kidneys and pancreas

• Assessment of lungs and other organs

• Blood testing

• Surgical exploration in selected cases

Because hepatic metastasis has been so common in published cases, a stomach mass should not be assessed in isolation. (PubMed)

How Worried Should You Be?

Lower Immediate Concern

The dragon:

• Misses one scheduled meal

• Remains bright and active

• Maintains normal weight

• Has normal stool

• Shows no regurgitation

• Has an identifiable husbandry or seasonal explanation

Action: Check temperatures, lighting and feeding records. Weigh the dragon and monitor closely rather than assuming cancer.

Moderate Concern

The dragon:

• Eats less over several scheduled feeds

• Is gradually losing weight

• Is less active

• Produces abnormal stool

• Has intermittent regurgitation

• Is not improving after husbandry correction

Action: Arrange a reptile veterinary examination within the next few days. Bring weight records and enclosure details.

High Concern

The dragon has:

• Progressive anorexia

• Marked weight or muscle loss

• Repeated regurgitation

• Anaemia

• Severe unexplained hyperglycaemia

• A palpable abdominal mass

• Gastric or liver abnormalities on imaging

• Black or bloody droppings

Action: Seek same-day or next-day reptile veterinary care. Imaging and tissue sampling should be considered promptly.

Critical

The dragon has:

• Collapsed

• Become minimally responsive

• Developed severe weakness

• Repeatedly regurgitated

• Passed substantial black or fresh blood

• Developed laboured breathing

• Become unable to stand

• Developed rapidly increasing abdominal swelling

• Stopped eating and is deteriorating rapidly

Action: Attend an emergency exotic veterinary service immediately.

When Is This an Emergency?

Seek urgent veterinary care if your bearded dragon develops:

• Black, tarry droppings

• Fresh blood from the mouth or cloaca

• Repeated vomiting or regurgitation

• Collapse

• Profound weakness

• Inability to support the body

• Open-mouth or laboured breathing outside normal basking behaviour

• Rapid abdominal enlargement

• Severe dehydration

• Minimal responsiveness

• Seizures or marked incoordination

• Rapid deterioration over a few hours

Gastric ulceration may cause substantial blood loss, while a large abdominal mass or widespread disease can impair digestion, circulation and respiration. (Sage Journals)

What To Do Right Now

1. Call an exotic or reptile veterinarian. Tell the clinic about blood, regurgitation, breathing changes, weight loss and any previous glucose result.

2. Minimise handling. A weak reptile can deteriorate with excessive restraint.

3. Maintain the established species-appropriate temperature range. Do not suddenly overheat the enclosure in an attempt to stimulate appetite.

4. Do not force-feed a regurgitating dragon. Food may be aspirated or remain within a poorly functioning stomach.

5. Use a low, secure transport container. Prevent climbing, falling and chilling.

6. Bring all recent records. Include blood results, imaging, medication names, fluid treatments, weight records and supplement labels.

Can Gastric Neuroendocrine Carcinoma Be Treated?

There is currently no established, evidence-based treatment protocol for this cancer in bearded dragons.

The published evidence consists mainly of pathology series and diagnostic case reports. Most reported dragons had metastasis when the diagnosis was made, and many were diagnosed only at necropsy or euthanised because of advanced disease. (PubMed)

Could Surgery Help?

Surgery might be discussed when:

• The tumour appears solitary

• No liver or distant metastasis is found

• The lesion can be removed with viable stomach margins

• The dragon is stable enough for anaesthesia

• The owner understands the risk of microscopic spread

Possible surgery could involve removal of part of the affected stomach wall.

However, this tumour’s published behaviour creates major limitations:

• Metastasis is common.

• Small metastases may be missed by imaging.

• The tumour can infiltrate blood vessels and lymphatics.

• Gastric surgery in a small reptile is technically demanding.

• There is little published evidence establishing long-term control after resection.

Surgery should not be presented as reliably curative. It is a highly individual decision requiring advanced imaging and an experienced reptile surgeon.

Is Chemotherapy Available?

No chemotherapy protocol has been shown to control gastric neuroendocrine carcinoma reliably in bearded dragons.

Drugs used for mammalian neuroendocrine cancer cannot simply be scaled down and given to a reptile. Major uncertainties include:

• Reptile drug metabolism

• Effective dose

• Gastrointestinal absorption

• Bone-marrow effects

• Liver clearance

• Temperature-dependent pharmacology

• Whether the tumour is responsive at all

Referral to an exotic-animal oncology service may allow discussion of experimental or palliative options, but evidence remains extremely limited.

What Supportive Care May Be Used?

Depending on the dragon’s condition, supportive care may include:

• Carefully selected fluid therapy

• Pain relief

• Management of nausea or regurgitation

• Gastric protection where ulceration is suspected

• Nutritional support when swallowing and gastric movement are safe

• Treatment of secondary infection when documented

• Correction of husbandry abnormalities

• Monitoring and management of anaemia

• Palliative care focused on comfort

Supportive care cannot eliminate metastatic cancer. Its purpose is to stabilise the dragon, relieve suffering and preserve quality of life where possible.

Should a Dragon With This Cancer Be Force-Fed?

Not automatically.

Assisted feeding may be appropriate when:

• The stomach is still emptying

• Regurgitation is controlled

• No major obstruction exists

• The dragon can swallow safely

• Nutritional support is likely to improve stability

It may be unsafe when:

• The dragon repeatedly regurgitates

• A large stomach mass limits passage

• Gastric movement is poor

• The dragon is severely weak

• Aspiration risk is high

The feeding route, food, volume and frequency should be chosen by the treating veterinarian.

What Is the Prognosis?

For a confirmed gastric neuroendocrine carcinoma, the prognosis is generally poor to grave.

Reasons include:

• Early metastatic spread

• Frequent liver involvement

• Vascular and lymphatic invasion

• Gastric ulceration and bleeding

• Vague signs that delay diagnosis

• Limited treatment evidence

• Difficulty identifying microscopic metastasis

All ten dragons in the initial series had hepatic metastasis. In the later retrospective study, every gastric, oesophageal and intestinal neoplasm in the selected pathology population was associated with death or euthanasia. (PubMed)

There is no reliable evidence-based statement that every affected dragon survives only a particular number of weeks or months. Most reports do not contain enough treatment and follow-up information to create an accurate survival estimate.

A genuinely localised tumour detected before metastasis may offer more options, but the outcome remains uncertain.

How Do You Assess Quality of Life?

Monitor the dragon’s ability to:

• Eat voluntarily

• Maintain weight

• Bask

• Walk and support the body

• Breathe comfortably

• Pass stool without bleeding

• Remain hydrated

• Interact with the environment

• Rest without obvious distress

• Tolerate necessary medication and handling

Euthanasia should be discussed when the dragon has:

• Uncontrolled pain

• Repeated gastrointestinal bleeding

• Persistent regurgitation

• Progressive weakness

• Inability to eat safely

• Severe metastatic disease

• More distressed days than comfortable ones

• No realistic path to stabilisation

Choosing euthanasia in advanced cancer is not giving up. It may be the most protective treatment available when suffering can no longer be controlled.

Can This Cancer Be Prevented?

No proven preventive strategy exists.

There is currently no evidence that gastric neuroendocrine carcinoma is caused by:

• A particular food

• UVB lighting

• Calcium supplementation

• Obesity

• A specific infectious organism

• One recognised husbandry mistake

Researchers identified reduced neurofibromin expression within several tumours, suggesting that disturbance of the NF1 tumour-suppressor pathway might contribute. This remains a biological clue, not proof that the disease is inherited or that a commercial genetic test can predict it. (Sage Journals)

Good husbandry remains essential for overall health, but it cannot guarantee cancer prevention.

Is It Contagious or Zoonotic?

No.

Gastric neuroendocrine carcinoma is not an infectious disease and cannot spread:

• Between bearded dragons

• To other pets

• To people

Separate housing may still be needed if the affected dragon requires protected feeding, medication or reduced competition.

How Can It Be Detected Earlier?

The most realistic approach is attentive monitoring rather than universal cancer screening.

Weigh Your Dragon Regularly

Use an accurate gram scale and record the result.

A consistent downward trend is more useful than judging body condition through appearance alone.

Track Appetite

Record:

• Meals offered

• Food actually eaten

• Insect numbers

• Vegetable intake

• Regurgitation

• Changes in food preference

“Still eating occasionally” can conceal a substantial decline.

Watch the Droppings

Seek veterinary advice for:

• Black or tarry material

• Fresh blood

• Repeated diarrhoea

• A marked reduction in stool

• Persistent undigested material

Arrange Routine Reptile Examinations

A wellness examination may identify:

• Weight loss

• Muscle loss

• Anaemia

• A coelomic mass

• Husbandry concerns

• Changes that justify bloodwork or imaging

Routine whole-body CT for every healthy dragon is not supported by current evidence. Bloodwork and imaging should be selected according to age, clinical findings, previous results and individual risk.

Common Mistakes Owners Make

Assuming Young Dragons Cannot Develop Cancer

This cancer has been documented mainly in young bearded dragons.

Assuming Every Appetite Problem Is Husbandry or Parasites

Those causes are more common, but progressive signs that do not respond as expected require a wider investigation.

Treating High Glucose as a Diagnosis

Hyperglycaemia supports concern but cannot identify the tumour by itself.

Assuming Normal Glucose Rules It Out

Most dragons in the initial series did not have documented hyperglycaemia.

Repeating Antibiotics or Antiparasitic Treatment Without Reassessment

Temporary improvement or a coincidental positive faecal result should not prevent imaging when weight loss and anorexia continue.

Relying on Radiographs Alone

Small stomach lesions and early liver metastases may require ultrasound, CT or tissue sampling.

Force-Feeding Through Repeated Regurgitation

This can increase aspiration risk and may worsen discomfort.

Waiting Until a Mass Is Obvious

Some tumours were not grossly visible even during post-mortem examination.

Frequently Asked Questions

Is gastric neuroendocrine carcinoma the same as stomach cancer?

It is one specific type of stomach cancer arising from neuroendocrine cells. Bearded dragons can also develop lymphoma, adenocarcinoma, sarcoma and other gastrointestinal tumours.

Does severe hyperglycaemia prove my bearded dragon has this cancer?

No. It becomes an important clue when combined with progressive appetite loss, weight loss, anaemia and gastric or liver masses. Treatment history and other metabolic causes must also be considered.

Can ultrasound diagnose the tumour?

Ultrasound can identify suspicious stomach or liver masses and guide sampling. Cytology or histopathology is still required to determine the tumour type.

Can surgery cure a bearded dragon with gastric neuroendocrine carcinoma?

A truly localised tumour might be surgically resectable, but there is very little outcome evidence and hidden metastasis is a major concern. Most reported cases were already metastatic when diagnosed.

Should every healthy young bearded dragon be screened?

There is no validated cancer-screening protocol. Regular weight monitoring, routine examinations and prompt investigation of persistent gastrointestinal signs are currently more useful than relying on glucose testing alone.

Final Thoughts

Gastric neuroendocrine carcinoma is rare, but it deserves a place on the differential list when a young bearded dragon develops persistent appetite loss, weight loss, weakness, regurgitation or gastrointestinal bleeding.

The most important points are:

1. Young age does not rule cancer out.

2. The signs are usually vague.

3. Hyperglycaemia can be an important clue but is not diagnostic.

4. Normal bloodwork or basic radiographs do not completely exclude the tumour.

5. Ultrasound, CT and cytology can support an ante-mortem diagnosis.

6. Histopathology remains the strongest confirmation.

7. Metastasis, especially to the liver, is common.

8. No validated chemotherapy or curative treatment protocol currently exists.

9. Early investigation may provide more options, but the prognosis remains guarded.

10. Quality of life must guide treatment decisions.

The right response is not to assume that every dragon skipping food has cancer. It is to stop dismissing progressive gastrointestinal illness when the expected treatment is not working.

---

ASK A VET™ can help you organise weight trends, appetite records, photographs of droppings, blood results and imaging reports while you work with a reptile veterinarian. A bearded dragon with repeated regurgitation, black droppings, collapse, severe weakness or breathing difficulty still requires immediate hands-on exotic veterinary care.